- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/6553 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
Patent holdings for IPC class C07F 9/6553
Total number of patents in this class: 131
10-year publication summary
10
|
11
|
9
|
10
|
6
|
7
|
5
|
7
|
7
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Royal Institution for The Advancement of Learning / McGill University | 688 |
7 |
Bristol-myers Squibb Company | 4881 |
6 |
Evonik Oxeno GmbH & Co. KG | 324 |
6 |
Allergan, Inc. | 2340 |
5 |
Merck Sharp & Dohme LLC | 3749 |
4 |
Merck Patent GmbH | 5812 |
3 |
Ischemix LLC | 16 |
3 |
Kyulux, Inc. | 234 |
3 |
Mitsubishi Tanabe Pharma Corporation | 584 |
3 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 830 |
3 |
Immunogenesis, Inc. | 19 |
3 |
LG Chem, Ltd. | 17641 |
2 |
Merck & Co., Inc. | 317 |
2 |
Boehringer Ingelheim International GmbH | 4641 |
2 |
DSM IP Assets B.V. | 5589 |
2 |
Idemitsu Kosan Co., Ltd. | 4227 |
2 |
Agfa-Gevaert | 287 |
2 |
Alla Chem, LLC | 56 |
2 |
Board of Regents of The Nevada System of Higher Education, on Behalf of The University of Nevada, Las Vegas | 151 |
2 |
Gilead Sciences, Inc. | 2035 |
2 |
Other owners | 67 |